The independent platform for news, articles and advice for professionals in laboratory medicine

Randox set to release eight new Quality Controls

Randox offers an extensive product offering comprising third-party quality controls and calibrators, interlaboratory data management, external quality assessment, calibration verification and molecular IQC and EQA for infectious disease testing. Randox Quality Control is now set to add eight Quality Controls to its range.

With approximately 70% of clinical decisions based on laboratory test results, it is essential that the results provided are accurate and reliable to prevent potential misdiagnosis or inappropriate treatment.

The new products are:

Active Vitamin B12 Control – The Acusera Active B12 Control is designed to deliver a cost-effective, high-quality solution for use in the quantitative determination of Active Vitamin B12 in human serum and plasma.

Anti-Mullerian Hormone (AMH) Control – The Randox Acusera AMH control is designed to use as a third-party control for the quantitative determination of Anti-Mullerian Hormone (AMH).

Brain Natriuretic Peptide (BNP) Control – Providing a true third-party solution, the new Acusera BNP Control is designed for use with in vitro diagnostics assays for the quantitative determination of BNP in human serum and plasma. The BNP control delivers an unbiased, independent assessment of analytical performance, helping to ensure accurate and reliable patient testing for BNP.

Bone Markers (Serum) Control – The lyophilised Serum Bone Marker Control is intended for use with in vitro diagnostic assays for the quantitative determination of Procollagen Type 1 N-Terminal Propeptide (P1NP), Osteocalcin (OC) and Bone Alkaline Phosphatase (B-ALP) in serum samples. This lyophilised Serum Bone Marker Control is assayed with target value and is suitable for use on automated analysers.

Pre-Eclampsia Control – The Pre-Eclampsia Control is intended for use with in vitro diagnostic assays for the quantitative determination of placental growth factor (PIGF) and soluble fms-like tyrosine kinase-1 (sFlt-1) in human serum and plasma. The Pre-Eclampsia Control is assayed with target values and is suitable for use on various immunoassay analysers.

Serum Indices Control – Intended for IVD use to monitor an instrument’s response to, and ability to detect haemolysed, icteric or lipaemia samples which can impact patient test results. The Acusera Serum Indices Control is qualitatively ranked and reported as -, =, == for Haemolysis, Icterus, and Lipaemia.

Xanthochromia Control – Randox Acusera Xanthochromia Quality Control is designed to deliver a cost-effective, high-quality solution for use in monitoring the performance of bilirubin and oxyhaemoglobin in cerebrospinal fluid (CSF) using a spectrophotometer.

(PSA) Ultra Low Control: This is intended for use with in vitro diagnostic assays for the quantitative determination of low levels of prostate-specific antigen (PSA) in human serum and plasma. This control delivers a true-third party solution for use in monitoring the performance. The PSA Ultra Low Control is assayed with target values and is suitable for use on various analysers, and for use of trained laboratory professionals and can be used in determining the precision of testing systems and in identifying sources of variation.

 

Upcoming Events

POCT Innovators: The Power to Disrupt Series

Cloth Hall Court, Leeds. UK
20 March, 2024

Interpreting Reports: UK NEQAS Haematology

ONLINE
21st March 2024

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Upcoming Events

POCT Innovators: The Power to Disrupt Series

Cloth Hall Court, Leeds. UK
20 March, 2024

Interpreting Reports: UK NEQAS Haematology

ONLINE
21st March 2024

USCAP 113th Annual Meeting

Baltimore Convention Center, Baltimore, Maryland, USA
23-28 March, 2024

Pathology Horizons 2024

MacDonald Bath Spa Hotel, Bath
18-20 April, 2024

Diagnostics North East Conference 2024

The Catalyst, Newcastle upon Tyne
19 April, 2024

ECCMID 2024 - European Congress of Clinical Microbiology and Infectious Diseases

Fira Gran Via, 08038 Barcelona, Spain
27-30 April 2024

Access the latest issue of Pathology In Practice on your mobile device together with an archive of back issues.

Download the FREE Pathology In Practice app from your device's App store

Step Communications Ltd, Step House, North Farm Road, Tunbridge Wells, Kent TN2 3DR
Tel: 01892 779999
www.step-communications.com
© 2024 Step Communications Ltd. Registered in England. Registration Number 3893025